On September 27-28 2018, the FDA Division of Transplant and Ophthalmology Products (DTOP) is hosting a two-day public workshop at the White Oak Campus in Silver Spring, MD entitled, Evidence-Based Treatment Decisions in Transplantation – The Right Dose for the Right Patient: Individualized Treatment. This collaborative workshop will be hosted in partnership with the Transplant Therapeutics Consortium and registration information will be announced ahead of the meeting through the Federal Register.
If you would like more information when it becomes available, please fill out this short survey.